Compared with chemotherapy, PD-1 or PD-L1 inhibitors had more risk of serious pneumonitis and hypothyroidism, which are similar results to the meta-analyses by Zhang et al. and Wang et al. [33,34]. The gene discussed is PDCD1; the disease is pneumonitis.